NASDAQ
Eledon Pharmaceuticals, Inc. (ELDN) has a current ratio of 7.40x as of Monday, May 25, 2026. This represents a 47.25% decrease compared to its 12-month average of 14.02x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.